Income Statement
ANIXA BIOSCIENCES INC
ANIX
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Oct 31, 2025 2025 FY | Oct 31, 2024 2024 FY | Oct 31, 2023 2023 FY | Oct 31, 2022 2022 FY | Oct 31, 2021 2021 FY | Oct 31, 2020 2020 FY | Oct 31, 2019 2019 FY | Oct 31, 2018 2018 FY | Oct 31, 2017 2017 FY | Oct 31, 2015 2015 FY | Oct 31, 2014 2014 FY | Oct 31, 2012 2012 FY | Oct 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
- | - | 0.21 | - | 0.51 | - | 0.25 | 1.11 | 0.36 | 9.26 | 3.67 | 0.95 | 1.00 |
|
Cost of Revenue
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Gross Profit
|
- | - | 0.21 | - | 0.51 | - | 0.25 | 1.11 | 0.36 | 9.26 | 3.67 | 0.95 | 1.00 |
|
Operating Expenses
|
11.70 | 13.83 | 11.06 | 13.88 | 13.26 | 9.98 | -12.14 | 13.72 | 6.01 | 6.23 | 6.41 | 5.08 | 6.00 |
|
Research & Development
|
5.07 | 6.40 | 4.77 | 6.70 | 6.19 | 4.38 | 5.47 | 6.81 | 1.60 | - | - | 2.21 | 3.12 |
|
Selling, General & Administrative
|
6.63 | 7.44 | 6.29 | 7.17 | 7.07 | 5.60 | 5.66 | 6.91 | 4.41 | 6.23 | 6.41 | 2.87 | 2.87 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-11.70 | -13.83 | -10.85 | -13.88 | -12.75 | -9.98 | -10.89 | -12.61 | -5.65 | 3.03 | -2.74 | -4.13 | -4.99 |
|
Non-Operating Income
|
- | - | - | - | - | - | 0.93 | 1.63 | -0.64 | 4.41 | 6.86 | 0.12 | 1.78 |
|
Interest Income
|
0.67 | 1.13 | 1.08 | 0.10 | 0.00 | 0.03 | 0.07 | 0.05 | 0.02 | 0.02 | 0.01 | 0.01 | 0.00 |
|
Interest Expense
|
- | - | - | - | - | - | - | - | 0.50 | 0.45 | 1.26 | 0.01 | - |
|
Other Non-Op Income / Expense
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Income Before Tax
|
- | - | - | - | - | - | -11.82 | -14.24 | -5.01 | -1.38 | -9.61 | -4.25 | -6.78 |
|
Income Tax Expense
|
- | - | - | - | - | - | - | -0.25 | 2.01 | 0.00 | 0.00 | 0.00 | 0.60 |
|
Non-Controlling Interest
|
-0.10 | -0.14 | -0.12 | -0.18 | -0.17 | -0.07 | -0.17 | -0.25 | - | - | - | - | - |
|
Net Income
|
-10.93 | -12.55 | -9.81 | -13.60 | -12.95 | -10.02 | -0.17 | -14.00 | -7.02 | -1.38 | -9.61 | -4.25 | -7.38 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Oct 31, 2025 2025 FY | Oct 31, 2024 2024 FY | Oct 31, 2023 2023 FY | Oct 31, 2022 2022 FY | Oct 31, 2021 2021 FY | Oct 31, 2020 2020 FY | Oct 31, 2019 2019 FY | Oct 31, 2018 2018 FY | Oct 31, 2017 2017 FY | Oct 31, 2015 2015 FY | Oct 31, 2014 2014 FY | Oct 31, 2012 2012 FY | Oct 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-11.70 | -13.83 | -10.85 | -13.88 | -12.75 | -9.98 | -10.89 | -12.59 | -5.60 | 3.03 | -2.74 | -4.12 | -4.99 |
|
Earnings Per Share (Basic)
|
-0.34 | -0.39 | 0.32 | -0.45 | - | - | - | - | - | - | - | 0.00 | - |
|
Diluted EPS
|
-0.34 | -0.39 | 0.32 | - | - | - | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
0.03 | 0.03 | 0.03 | - | - | - | - | - | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
0.03 | 0.03 | 0.03 | 30.37 | - | - | - | - | - | - | - | - | - |
|
Comprehensive Income
|
- | - | - | - | - | - | - | - | - | - | -9.61 | - | - |